Octreotide treatment in a neonate with non-chylous pleural effusion.
Fetal pleural effusion is a rare condition. While it may regress spontaneously, it may also continue up to the post-natal period. This condition may be treated by thoracentesis, thoracoabdominal shunt application and pleurodesis in the intrauterine period while thoracentesis or tube thoracostomy may be used in the post-natal period. In cases where the fluid is defined to represent chylothorax, octreotide, a somatostatin analogue, may be administered for treatment. In this case report, we discussed the outcomes of treatment with octreotide administered in a neonatal case under follow-up due to fetal pleural effusion and with non-chylous ascites detected in the post-natal period.
Department of Pediatrics, Division of Neonatology, School of Medicine, Akdeniz University, Konyaalti, Antalya, Turkey.
Salih
S
Kalay
Osman
O
Oztekin
Gonul
G
Tezel
Burak Emre
BE
Demir
Mustafa
M
Akcakuş
Nihal
N
Oygur
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004305:Dose-Response Relationship, Drug; D004322:Drainage; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D010996:Pleural Effusion / Q000000981:diagnostic imaging / Q000628:therapy*; D011247:Pregnancy; D013902:Radiography, Thoracic; D016216:Ultrasonography, Prenatal
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide